Reference Library

    Cannabinoids & Terpenes

    Neutral descriptions that separate established facts from marketing claims.

    THC

    Intoxicating cannabinoid. Can impair judgment, coordination and reaction time. Higher doses increase adverse-effect risk.

    CBD

    Non-intoxicating cannabinoid that can interact with medications. Retail products are not equivalent to approved prescription medicines.

    THCA

    Acidic precursor that converts partly to THC when heated.

    CBDA

    Acidic precursor related to CBD.

    CBG

    Minor cannabinoid under active research; broad health claims are not established.

    CBN

    Minor cannabinoid often marketed for sleep, but strong clinical evidence is limited.

    Delta-8 THC

    Synthetically derived from hemp CBD. Intoxicating. Regulatory status varies by jurisdiction.

    Myrcene

    Terpene with an earthy aroma. Consumer-reported effects are not guaranteed medical outcomes.

    Limonene

    Citrus-scented terpene. Claims about mood elevation are not established by clinical evidence.

    Caryophyllene

    Spicy, peppery terpene. Sometimes described as a dietary cannabinoid, but product claims are unproven.

    Linalool

    Floral terpene found in lavender and cannabis. Relaxation claims are not clinically established for cannabis products.

    Pinene

    Pine-scented terpene present in many plants. Evidence for consumer cannabis claims is limited.

    Humulene

    Earthy, hoppy terpene. Health claims for cannabis products are not established by strong evidence.

    These descriptions are educational summaries. Compound research is ongoing; entries are updated as evidence changes.